Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer.

Saved in:
Bibliographic Details
Title: Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer.
Authors: Fukushiro-Lopes DF; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA., Hegel AD; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA., Rao V; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA.; Research Service, Edward Hines Jr. VA Hospital, Hines, IL, USA., Wyatt D; Department of Pathology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA., Baker A; Department of Pathology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA., Breuer EK; Department of Pathology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA., Osipo C; Department of Pathology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA., Zartman JJ; Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, IN, USA., Burnette M; Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, IN, USA., Kaja S; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA.; Department of Ophthalmology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA.; Research Service, Edward Hines Jr. VA Hospital, Hines, IL, USA., Kouzoukas D; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA., Burris S; Cardiovascular Research Institute, Loyola University Chicago, Maywood, IL, USA., Jones WK; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA., Gentile S; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA.
Source: Oncotarget [Oncotarget] 2017 Dec 04; Vol. 9 (3), pp. 3321-3337. Date of Electronic Publication: 2017 Dec 04 (Print Publication: 2018).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.22925